STDs
Binx Health Raises $104M in Series E Round
The Boston-based company said it will use the funds to ramp up manufacturing of its FDA-cleared Binx io molecular point-of-care instrument, among other things.
SpeeDx Inks Distribution Deal for Infectious Disease Tests in Turkey
The deal covers SpeeDx's ResistancePlus and PlexPCR product lines, which include tests for sexually transmitted infections and antibiotic resistance.
The company said the improvements it has made to its business during the pandemic will translate to significant increases in growth once it ends.
Qiagen has benefited from unexpected tailwinds due to COVID-19 testing and envisions post-pandemic growth with recently acquired NeuMoDx as a key contributor.
FDA Provides Second Clearance for Binx MDx Platform
The FDA cleared the point-of-care Binx io platform for the detection of chlamydia and gonorrhea in male urine specimens.
Mar 4, 2020
Randox Laboratories STI Assay Gets CE Mark
Feb 11, 2020
SpeeDx Raises Additional $15M
Jan 13, 2020
SpeeDx, LabCorp Will Codevelop MDx Tests
Nov 14, 2019
Linear Diagnostics Lands £2M Investment
Oct 15, 2019
Enzo Biochem Fiscal Q4 Revenues Down 8 Percent
Aug 5, 2019
Lucira Health Closes $15M Series B Financing
Apr 25, 2019
Apr 15, 2019